All

Results: 33853-33864 of 48202

AM Best to Participate at 2024 XPRIMM IIF – ESG In Insurance Conference

Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award

Eco Wave Power Announces 1,076% Revenue Increase, Investment Agreement with Major Energy Company for its LA Project, and Final License for the Construction of its First Commercial Project in Portugal

PR Newswire associated0

Veeva Vault CRM Now Available for All New Customers

Dave & Buster's Entertainment, Inc (Photo: Business Wire)

Dave & Buster’s International Growth Momentum Continues

PR Newswire associated0

Clarivate Leadership Presents at Recent Investor Conferences

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

PR Newswire associated0

MADISON INTERNATIONAL REALTY EXPANDS GLOBAL PRESENCE WITH NEW OFFICE IN SINGAPORE

PR Newswire associated0

Ridgewood Infrastructure Announces Structured Equity Investment in MN8 Energy, One of America's Largest Privately Owned Solar Energy Companies

PR Newswire associated0

Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

Business Wire logo

Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease

Peter Carbone, KBI Biopharma Chief Quality Officer (Photo: Business Wire)

KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer